A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies
Clinical trial NCT05269940 · COMPLETED
Trial details
- NCT number
- NCT05269940
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2023-01-24
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.